Publications

Jump to: Abstracts

Peer reviewed manuscripts

  1. Purdy JA, Harms WB, Michalski JM, Bosch WR. Initial Experience with Quality Assurance of Multi-Institutional 3D Radiotherapy Clinical Trials. Strahlenther Onkol 174(II):40-42, 1998.
  2. Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys, 57(3):614-20, 2003.
  3. Roach M, Winter K, Michalski JM, Cox JD, Purdy JA, Bosch W, Lin X, Shipley WS. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys, 60(5):1351-1356, 2004.
  4. Bradley JD, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma. Int J Radiat Oncol Biol Phys, 61(2):318-328, 2005.
  5. Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys, 62(3):706-713, 2005.
  6. Matthews JW and Bosch WR. Explicit-VR Transfer Syntax Limits the Value Multiplicity of DICOM Data Elements with Decimal String (DS) Value Representation. Phys Med Biol, 51(5):L11-2, 2006.
  7. Bradley JD, Hope A, El Naqa I, Apte A, Lindsay PE, Bosch W, Matthews J, Sause W, Graham MV, Deasy JO. A Nomogram to Predict Radiation Pneumonitis, Derived from a Combined Analysis of RTOG 9311 and Institutional Data. Int J Radiat Oncol Biol Phys, 69(4):985-992, 2007.
  8. Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, Bosch WR, Michalski J, Galvin JM. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 73(4):1235-1242, 2009.
  9. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapyoncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys, 74(3):824-830, 2009.
  10. Eisbruch A, Harris J, Garden AS, Chao KS, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK. Multi-institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early Stage Oropharyngeal Cancer (RTOG 00-22). Int J Rad Onc Biol Phys, 76(5):1333-1338, 2010.
  11. Michalski JM, Lawton C, El Naqa I, Ritter M, O’Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zeitman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys, 76(2):361-368, 2010.
  12. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK., Cheung MR, Thames HD, Cox JD. Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model. Int J Rad Onc Biol Phys, 78(4):1253-1260, 2010.
  13. Allozi R, Li XA, White J, Apte A, Tai A, Michalski JM, Bosch WR, El Naqa I.
    Tools for consensus analysis of experts’ contours for radiotherapy structure definitions.  Radiother Oncol, 97(3):572-578, 2010.
  14. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, May Nr, Viswanathan A, Jhingran A, Erickson B, De Los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, FylesA and Gyn IMRT Consortium. Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer. Int J Rad Onc Biol Phys, 79(2):348-355, 2011.
  15. Cui Y, Galvin JM, Straube WL, Bosch WR, Purdy JA, Li XA, Xiao Y. Multi-System Verification of Registrations for Image-Guided Radiotherapy in Clinical Trials.  Int J Rad Onc Biol Phys, 81(1):305-12, 2011.
  16. Wang D, Bosch W, Kirsh DG, Al Lozi R, El Naqa I, Roberge E, Finkelstein SE, Petersen I, Haddock M, Chen YE, Saito NG, Hitchcock YJ, Wolfson AH, DeLaney TF. Variation in the Gross Tumor Volume and Clinical Target Volume for Preoperative Radiotherapy of Primary Large High-Grade Soft Tissue Sarcoma of the Extremity Among RTOG Sarcoma Radiation Oncologists. Int J Rad Onc Biol Phys, 81(5):e775-80, 2011.
  17. Tucker SL, Thames HD, Michalski JM, Bosch WR, Mohan R, Winter K, Cox JD, Purdy JA, Dong L. “Estimation of α/β for Late Rectal Toxicity Based on RTOG 94-06,” Int J Rad Onc Biol Phys, 81(2):600-605, 2011.
  18. Huang EX, Bradley JD, El Naqa I, Hope AJ, Lindsay PE, Bosch WR, Matthews JW, Sause WT, Graham MV, Deasy JO. “Modeling the Risk of Radiation-Induced Acute Esophagitis for Combined Washington University and RTOG Trial 93-11 Lung Cancer Patients,” Int J Rad Onc Biol Phys, 82(5):1674-1679, 2012.
  19. Gay HA, Barthold HJ, O’Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H,  Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W, Gaffney D, Viswanathan AN, Michalski JM. Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel Atlas.  Int J Rad Onc Biol Phys, 83(3):e353-e362, 2012.
  20. Goodman KA, Regine WF, Dawson LA, Ben-Josef E, Haustermans K, Bosch WR, Turian J, Abrams RA. Radiation Therapy Oncology Group Consensus Panel Guidelines for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Head Cancer. Int J Rad Onc Biol Phys, 83(3):901-908, 2012.
  21. Santanam L, Hurkmans C, Mutic S, van Vliet-Vroegindeweij C, Brame S, Straube W, Galvin J, Tripuraneni P, Michalski J, Bosch W. Standardizing Naming Conventions in Radiation Oncology. Int J Rad Onc Biol Phys, 83(4):1344-1349, 2012.
  22. Tucker SL, Dong L, Michalski JM, Bosch WR, Winter K, Cox JD, Purdy JA, Mohan R. Do Intermediate Radiation Doses Contribute to Late Rectal Toxicity? An Analysis of Data From Radiation Therapy Oncology Group Protocol 94-06. Int J Rad Onc Biol Phys, 84(2):390-395, 2012.
  23. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YE, DeLaney TF, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH. In Reply to O’Sullivan et al. Int J Rad Onc Biol Phys, 84(2):307-308, 2012.
  24. Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiother Oncol. 104(1):109-13, 2012, PMCID: PMC3413409
  25. Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. Brachytherapy, 12(1):19-24, 2013.
  26. Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, DeLaney TF, Abrams RA, Indelicato DJ, Baldini EH, Hitchcock Y, Kirsch DG, Kozak KR, Wolfson A, Wang D. Agreement Among RTOG Sarcoma Radiation Oncologists in Contouring Suspicious Peritumoral Edema for Preoperative Radiation Therapy of Soft Tissue Sarcoma of the Extremity. Int J Rad Onc Biol Phys, 86(2):298-303, 2013.
  27. Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM. Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial. Int J Rad Onc Biol Phys, 87(5):932-938, 2013.
  28. Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K , Hunt M, Kessler M, Lawton CA, Mayo C, Michalski JM, Mutic S, Potters L, Rose CM, Sandler HM, Sharp G, Tomé W, Tran PT, Wall T, Zietman AL, Gabriel PE, Bekelman JE. Practice-Based Evidence to Evidence-Based Practice: Building the National Radiation Oncology Registry. J Onc Pract, 9(3):e90-e95, 2013.
  29. Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, Ben-Josef E, Crane CH, Goodman KA, Haddock MG, Herman JM, Hong TS, Kachnic LA, Mamon HJ, Pantarotto JR, Dawson LA. Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus. Pract Radiat Oncol, 4(2):82-89, 2014.
  30. Noel CE, Gutti VR, Bosch W, Mutic S, Ford E, Terezakis S, Santanam L. Quality Assurance With Plan Veto: Reincarnation of a Record and Verify System and Its Potential Value. Int J Rad Onc Biol Phys, 88(5):1161-1166, 2014.
  31. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver Variability in Target Definition for Hepatocellular Carcinoma With and Without Portal Vein Thrombus: Radiation Therapy Oncology Group Consensus Guidelines. Int J Rad Onc Biol Phys, 89(4):804-813, 2014.
  32. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Burnett III OL, D’Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small Jr. W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer. Int J Rad Onc Biol Phys, 90(2):320-328, 2014.
  33. Yu J, Straube W, Mayo, Tawfik Giaddui T, Bosch W, Ulin K, Kry SF, Galvin J, Xiao Y. Radiation Therapy Digital Data Submission Process for National Clinical Trials Network. Int J Rad Onc Biol Phys, 90(2):466-467, 2014.
  34. Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ulin K, Ishikura S, Followill D, Galvin J, Haworth A, Besuijen D, Clark CH, Miles E, Aird E, Weber DC, Hurkmans CW, Verellen D. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. Int J Rad Onc Biol Phys, 90(5):1242-1249, 2014.
  35. Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ishikura S, Followill D, Galvin J, Xiao Y, Ebert MA, Kron T, Clark CH, Miles EA, Aird EG, Weber DC, Ulin K, Verellen D, Hurkmans CW. Radiation therapy quality assurance in clinical trials–Global Harmonisation Group. Radiother Oncol, 111(3):327-9, 2014.
  36. Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, BÃttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, LÃhr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, WhitfieldG, Zackrisson B, Zips D, Baumann M. Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets. Radiother Oncol, 113(3):303-9, 2014.
  37. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer, 121(13):2156-63, 2015.
  38. Moore KL, Schmidt R, Moiseenko V, Olsen LA, Tan J, Xiao Y, Galvin J, Pugh S, Seider MJ, Dicker AP, Bosch W, Michalski J, Mutic S. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126. Int J Rad Onc Biol Phys, 92(2):228-35, 2015.
  39. Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin M, Xiao C, Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, Sandler HM. Preliminary patient-reported outcomes analysis of 3-dimensionalradiation therapy versus intensity-modulated radiation therapy on the high-dosearm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. Cancer, 121(14):2422-30, 2015.
  40. Baldini EH, Bosch W, Kane JM 3rd, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal Sarcoma (RPS) High Risk Gross Tumor Volume Boost (HR GTV Boost) Contour Delineation Agreement Among NRG Sarcoma Radiation and Surgical Oncologists.  Ann Surg Oncol, 22(9):2846-52, 2015.
  41. Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Hamstra DA, Bosch W, Gay H, Michalski J. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. Int J Rad Onc Biol Phys, 92(5):971-7, 2015.
  42. Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR Jr, Goodman KA. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Rad Onc Biol Phys, 92(4):911-20, 2015.
  43. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Rad Onc Biol Phys, 92(5):1053-9, 2015.
  44. Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol, 5(6):e557-65, 2015.
  45. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys, 95(4):1191-1200, 2016.
  46. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra A, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys, 96(1):78-86, 2016.
  47. Fischer-Valuck BW, Chundury A, Gay HA, Bosch W, Michalski J. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall. Pract Radiat Oncol, 7(3):195-202, 2017.
  48. Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. J Clin Oncol, 35(1):56-62, 2017.
  49. Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, Bosch W, Straube W, Mell LK, Moore KL, Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials. Int J Rad Onc Biol Phys, 97(1):164-172, 2017.
  50. Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ; INTERTECC Study Group. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). Int J Rad Onc Biol Phys, 97(3):536-545, 2017.
  51. Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Daignault-Newton S, Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Rad Onc Biol Phys, 97(5):976-985, 2017.

Abstracts

  1. Straube W, Bosch W, Haynes R, Eccher A, Matthews J, Purdy J. Update On Digital Data Integrity Quality Assurance for Multi-Institutional Advanced Technology Clinical Trials. Med Phys, 35(6):2811, 2008.
  2. Bosch W, Matthews J, Deasy J, Michalski J, Straube W, Purdy J. QuASA2R — a Digital Data Quality Assurance Submission, Archive, Analysis, and Review System for Advanced Technology Clinical Trials in Radiation Therapy. Med Phys, 35(6):2813, 2008.
  3. Tucker SL, Dong L, Michalski JM, Bosch W, Winter K, Mohan R, Kuban D, Cheung MR, Lee AK, Cox JD. Risk Factors for Grade 2+ Late Bladder Toxicity among Patients Treated on Protocol RTOG 94-06. Int J Radiat Oncol Biol Phys, 72(1):S65-S66, 2008.
  4. Lee N, Harris J, Garden AS, Straube W, Bosch W, Morrison WH, Quivey J, Thorstadt W, Jones C, Ang KK. Phase II Multi-institutional Study of Intensity Modulated Radiation Therapy (IMRT) +/− Chemotherapy for Nasopharyngeal (NPC) Carcinoma: Preliminary Clinical Results of RTOG 0225. Int J Radiat Oncol Biol Phys, 72(1), S98, 2008.
  5. Eisbruch A, Harris J, Garden AS, Chao CKS, Straube W, Harari PM, Sanguineti G, Jones C, Bosch W, Ang KK. Multi-institutional Trial of IMRT for Early Stage Oropharyngeal Cancer: Acceleration via Simultaneously Incorporated Boost (SIB) (RTOG 00-22). Int J Radiat Oncol Biol Phys, 72(1), S99, 2008.
  6. Straube WL, Bosch WR, Matthews JW, Michalski JM, O’Meara E, Purdy JA. Impact of Protocol Complexity on Digital Data Integrity Quality Assurance for Clinical Trials Requiring Digital Data Submission. Int J Radiat Oncol Biol Phys, 72(1):S668, 2008.
  7. Ulin K, Yorty J, Hanusik R, Urie M, Bosch WR, Apte A, Khullar D, Deasy JO, Fitzgerald TJ. Use of CERR at the Quality Assurance Review Center to Assess Protocol Compliance of Radiation Therapy Treatment Plans Submitted in Digital Format. Int J Radiat Oncol Biol Phys, 72(1), S673, 2008.
  8. Apte A, Deasy J, Bosch W, El Naqa I. Tools and Methods for Consensus Generation From Experts’ Contours for Radiotherapy Structure Definition. Med Phys, 36(6):2712, 2009.
  9. Harrison AS, Anamalayil S, Timmerman R, Straube W, Bosch W, Michalski J, Galvin J, Xiao Y. A Feasibility Study and Optimization of Dosimetric Objective with Heterogeneity Corrections for RTOG Studies with Hypo-fractionated Stereotactic Radiotherapy of Lung Cancers. Int J Radiat Oncol Biol Phys, 75(3):S684, 2009.
  10. Straube WL, Bosch WR, Matthews JW, Goddu SM, Bennett WC, Michalski JM, Purdy JA. An Electronic Phantom for Testing and Quality Assurance of Dose Volume Histogram Calculations used in Data Analysis for Multi Institutional Clinical Trials. Int J Radiat Oncol Biol Phys, 75(3):S620-S621, 2009.
  11. Cui Y, Galvin JM, Straube WL, Bosch WR, Purdy JA, Li A, Xiao Y. Multi-system Verification of Registrations Utilized in IGRT Processes. Int J Radiat Oncol Biol Phys, 75(3):S99-S100, 2009.
  12. Fyles AW, Lim K, Small W, Portelance L, Gaffney D, Erickson B, de los Santos J, Ishikura S, Creutzberg C, Bosch W. Variability in Delineation of Clinical Target Volumes for Cervix Cancer Intensity-modulated Pelvic Radiotherapy. Int J Radiat Oncol Biol Phys, 75(3), S83-S84, 2009.
  13. Bennett W, Matthews J, Bosch W. Open-Source Tool for Assessing Variability in DICOM Data. Med Phys, 37(6):3245, 2010.
  14. Al-Lozi R, Li X, White J, Apte A, Tai A, Michalski J, Bosch W, El Naqa I. Validation Study of a Software Tool for Consensus Analysis of Experts’ Contours for Generating Atlases of Radiotherapy Target and Normal Structures. Med Phys, 37(6):3170, 2010.
  15. Wang D, Bosch W, Kirsch D, Lozi R, Naqa I, Roberge D, Finkelstein S, Petersen I, Saito N., DeLaney TF. Variations in the Gross Target Volume and Clinical Target Volume Evaluated by RTOG Sarcoma Radiation Oncologists for Preoperative Radiotherapy of Primary Extremity Sarcoma. Int J Radiat Oncol Biol Phys, 78(3):S620, 2010.
  16. Lim K, Fyles A, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Viswanathan A, Erickson B, Bosch W, El Naqa I, Varia M. Variability in Clinical Target Volume Delineation for Intensity Modulated Radiotherapy in Three Challenging Cervix Cancer Scenarios. Int J Radiat Oncol Biol Phys, 78(3):S121-S122, 2010.
  17. DeLaney TF., Bosch WR, Roberge D., Finkelstein SE, Petersen IA, Haddock MG, Chen YE, Saito NG, Kirsch DG, Wang D. RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume (GTV) and Clinical Target Volume (CTV) on Computed Tomography Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in RTOG Studies. Int J Radiat Oncol Biol Phys, 78(3):S87, 2010.
  18. Bosch WR, Paulus R, Michalski JM, Galvin J, Followill D, Prestidge BR, Bice WS, Sandler H, Hagan M. Analysis of Brachytherapy Plans for Regulatory Compliance: Dosimetric Study of RTOG 0232 Plans to Quantify Expected Dose to Organs at Risk. Int J Radiat Oncol Biol Phys, 81(2):S379, 2011.
  19. Devlin PM, Zelefsky MJ, Cohen GN, Nguyen PL, Crozier CL, Owen J, Rose CM, Wilson J, Bosch WR. Secure Web-based Remote Quality Assessment of Prostate Brachytherapy Treatment Plans for a Multi-institutional Patterns of Care/QRRO Survey: A Proof of Principle Study. Int J Radiat Oncol Biol Phys, 81(2):S209, 2011.
  20. Hagan M, Bosch W, Moore M, Prestidge B, Paulus R, Galvin J, Sandler H, Winter K, Michalski J. “Analysis Of Brachytherapy Plans For Regulatory Compliance: Application Of Expected Doses To Organs At Risk. Int J Radiat Oncol Biol Phys, 81(2):S387-S388, 2011.
  21. Zelefsky MJ, Cohen GN, Morikawa L, Devlin P, Bosch W, Crozier C, Lee W, Zietman A, Owen J, Wilson J. “Results from the Quality Research in Radiation Oncology (QRRO) Survey: Evaluation of Dosimetric Outcomes for Low Dose Rate Prostate Brachytherapy. Int J Radiat Oncol Biol Phys, 81(2):S389-S390, 2011.
  22. Bruner DW, Hunt D, Michalski JM, Bosch W, Yan Y, Galvin JM, Bahary J, Morton GC, Parliament MB, Sandler H. “Preliminary Analysis of 3D-CRT vs. IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Patient Reported Outcomes. Int J Radiat Oncol Biol Phys, 81(2):S389-S390, 2011.
  23. Mulhern JP, Fitzgerald T, Bosch W, Chen J, Siegel E, Jamijian A, O’Meara E, Freymann J, Kirby J, Purdy J. Bioinformatics Support of Cross Correlation of Images with RT Objects and Clinical Meta-data. Int J Radiat Oncol Biol Phys, 81(2):S160, 2011.
  24. Roberge D, Bosch W, Bahig H, Levin W, Petersen I, Haddock M, Freeman C, DeLaney T, Abrams R, Wang D. Interobserver Variation in Suspicious Edema Definition for Preoperative Radiation Therapy in Soft-tissue Sarcoma of the Extremity. Int J Radiat Oncol Biol Phys, 84(3):S168-S169, 2012.
  25. Michalski JM, Yan Y, Tucker S, Winter K, Bosch W, Galvin J, Bahary J, Morton G, Xiao Y, Sandler H. Dose Volume Analysis of Grade 2+ Late GI Toxicity on RTOG 0126 After High-dose 3DCRT or IMRT. Int J Radiat Oncol Biol Phys, 84(3):S14-S15 2012.
  26. Matuszak M, Xiao Y, Presley J, Bosch WR, Ten Haken RK, Galvin J, Werner-Wasik M, Machtay M, Bradley J, Kong F. The Importance of Dry Run Credentialing for RTOG 1106/ACRIN 6697: A Trial of Individualized Adaptive Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys, 84(3):S26-S27, 2012.
  27. Hong TS, Bosch WR, Crane CH, Dawson LA. Interobserver Variability in Target Definition for Hepatocellular Carcinoma (HCC) With and Without Portal Vein Thrombus: Radiation Therapy Oncology Group (RTOG) HCC Consensus Panel. Int J Radiat Oncol Biol Phys, 87(2) S28, 2013.
  28. Williams L, Belderbos JSA, Bosch WR, Kong F, Lebesque JV, Liu F, Rosenzweig KE, Straube WL, Ten Haken RK, Jackson A. Using gEUD to Model Volume Effects for Pneumonitis in Prospective Data From 4 Non-Small Cell Lung Cancer (NSCLC) Dose-Escalation Trials. Int J Radiat Oncol Biol Phys, 87(2) S45, 2013.
  29. Wu J, Goodman KA, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR, Bosch WR. Generation of Consensus Contour Atlas for Esophageal Cancer IMRT. Int J Radiat Oncol Biol Phys, 87(2) S293, 2013.
  30. Viswanathan AN, Erickson B, Beriwal S, D’Souza DP, Jones EL, Portelance L, Small W, Yashar CM, Gaffney DK, Bosch W. Consensus Contours for CT Versus MRI in Image-Based Brachytherapy for Cervix Cancer to Generate an RTOG Atlas. Int J Radiat Oncol Biol Phys, 87(2):S30, 2013.
  31. Baldini EH, Bosch W, Abrams RA, Roberge D, Olsen JR, Haas RL, Catton CN, Indelicato DJ, DeLaney TF, Wang D. Retroperitoneal Sarcoma (RPS) Target Volume and Organ at Risk (OAR) Contour Delineation Agreement Among RTOG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys, 90(1):S116-S117, 2014.
  32. Small W, Bosch WR, Strauss JB, Albuquerque K, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles TW, Jhingran A, Klopp AH, Kunos C, Mell LK, Powell M, Viswanathan AN, Yashar CM, Gaffney D. Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. Int J Radiat Oncol Biol Phys, 90(1) S109, 2014.
  33. Viswanathan AN, Buzurovic I, Damato AL, Bosch W, Gaffney D, Beriwal S, Burnett O, D’Souza D, Jhingran A, Jones EL, Kunos C, Lee L, Lin L, Mayr NA, Petersen I, Portelance L, Small W, Wolfson A, Yashar CM, Erickson B, Dosimetric Comparison Based on Consensus Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys, 90(1):S183, 2014.
  34. Moore KL, Schmidt R, Olsen L, Tan J, Xiao Y, Galvin J, Pugh S, Bosch WR, Michalski J, Mutic S. Suboptimal Treatment Planning Adds Substantial Risk of Normal Tissue Complication: A Secondary Study on RTOG 0126. Int J Radiat Oncol Biol Phys, 90(1):S821, 2014.
  35. W Bosch, L Olsen , W Straube , T DeWees , N Mariados , J Sylvester , D Shah , S Kurtzman , S Zimberg , J Michalski. Effect of Hydrogel Spacer On Achievable Rectal DVH for IMRT in Prostate Cancer. Med Phys, 42(6):3706, 2015.
  36. M Matuszak, J Moran, Y Xiao, C Mayo, W Bosch, R Popple, L Marks, Q Wu, A Molineu, R Miller, T Yock, T McNutt, N Brown, T Purdie, E Yorke, L Santanam, P Gabriel, J Michalski, J Moore, S Richardson, R Siochi, M Napalitano, K Ulin, T Fitzgerald, M Feng, W Verbakel, S Siddiqui, T Morgas, M Martel, Y Archambault, M Ladra, B Lansing, R Ruo, A Fogliata-Cozzi, C Hurkmans. AAPM Task Group 263 Tackling Standardization of Nomenclature for Radiation Therapy. Med Phys, 42(6):3231, 2015.
  37. R. Bosch, W. Straube, T.A. DeWees, N.F. Mariados, J.E. Sylvester, D.K. Shah, S. Kurtzman, S.H. Zimberg, J.M. Michalski. Dose Escalation Using a Hydrogel Spacer for Intensity Modulated Radiation Therapy in Prostate Cancer. Int J Radiat Oncol Biol Phys, Volume 93, Issue 3, Supplement, 1 November 2015, Page E213.
  38. Buzurovic, A.L. Damato, M.T. Studenski, C.L. Deufel, J. Huang, D.K. Gaffney, K. Hayeon, D.J. Scanderbeg, W.R. Bosch, B.A. Erickson, A.N. Viswanathan. Dosimetric Evaluations of CT and MR-Based Brachytherapy Treatment Plans for Cervical Cancers Using Consensus Contouring Atlases. Int J Radiat Oncol Biol Phys, Volume 93, Issue 3, Supplement, 1 November 2015, Pages E282-E283.
  39. Mayo C, Moran JM, Xiao Y, Bosch WR, Matuszak MM, Marks LB, Miller RC, Wu QRJ, Yock TI, Popple R, McNutt TR, Brown N, Molineu A, Purdie TG, Yorke ED, Santanam L, Gabriel P, Michalski JM, Moore J, Richardson S, Siochi RAC, Napolitano M, Feng M, Fitzgerald T, Ulin K, Verbakel WFAR, Siddiqui MSU, Martel MK, Archambault Y, Morgas T, Purcy J, Adams JA, Ladra M, Lansing B, Ruo R, Fogliata A, Hurkmans C. AAPM Task Group 263: Tackling Standardization of Nomenclature for Radiation Therapy. Int J Radiat Oncol Biol Phys, 93(3):E383-4, 2015.
  40. Chun G, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch WR, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn R, Raben A, Augspurger M, MacRae RM, Paulus R, Bradley JD. Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617. Int J Radiat Oncol Biol Phys, 93(3):S1-S2, 2015.
  41. Christodouleas JP, Baumann BC, Bosch WR, Bahl A, Birtle A, Breau R, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, Feldman AS, Guzzo T, Hilman S, Jani A, Malkowicz B, Master VA, Mitra A, Porten S, Efstathiou JA, Eapen L. Development and Validation of Contouring Guidelines for Postcystectomy Adjuvant Radiation of Bladder Cancer. Int J Radiat Oncol Biol Phys, 93(3):S24-S25, 2015.
  42. Li N, Carmona R, Sirak I, Kasaova L, Followill DS, Michalski JM, Bosch WR, Mell LK, Moore KL. Validation of a Knowledge-Based Automated Planning System in Cervical Cancer As a Clinical Trial Quality System. Int J Radiat Oncol Biol Phys, 93(3):S40. 2015.
  43. Watkins Bruner D, Deshmukh S, Michalski JM, Purdy JA, Bosch WR, Bahary JP, Patel M, Parliament MB, Lock MI, Lau H, Hamstra DA, Fisher SA, Souhami L, Kwok Y, Seider MJ, Vigneault E, Gay HA, Rosenthal SA, Sandler HM, Movsas B. Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys, 93(3):S199-S200, 2015.
  44. Mell LK, Sirak I, Wei L, Tarnawski RR, Mahantshetty UM, Yashar CM, McHale MT, Wright ME, Pritz J, Straube W, Xu R, Kasaova L, Michalski JM, Bosch WR, Followill DS, Schwarz JK, Honerkamp-Smith G, Leif JL, Saenz CC, Einck JP, Koonings PP, Harrison TA, Khorprasert C, Shi M, Plaxe SC, Mundt AJ III . Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer. Int J Radiat Oncol Biol Phys, 96(2): S13, 2016.
  45. Barkati M, King B, Fortin I, Portelance L, Viswanathan AN, Fyles TW, Beriwal S, Alfieri J, Lim KS, Harkenrider MM, Small W, Klopp AH, Stewart A, Yashar CM, Bosch WR, Jhingran A, Jolicoeur M, Gaffney DK. Intensity Modulated Radiation Therapy for Vulvar Carcinoma: Changes in Practice Over 5 Years. Int J Rad Onc Biol Phys, 96(2):E295-E296, 2016.
  46. Yashar CM, Petersen IA, Bosch WR, Albuquerque KV, Beriwal S, Chino JP, Erickson BA, Feddock J, Gaffney DK, Iyer R, Klopp AH, Kunos C, Mayadev JS, Portelance L, Viswanathan AN, Wolfson AH, Jhingran A, Mell LK. Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma. Int J Radiat Oncol Biol Phys, 96(2):S13-4, 2016.
  47. Viswanathan AN, Winter K, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis U, Horowitz N, Mannel R, Souhami L, Erickson BA, Small Jr W, Gaffney DK. Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer. Int J Radiat Oncol Biol Phys, 96(2):S49-50, 2016.
  48. Barkati M, King B, Fortin I, Portelance L, Viswanathan AN, Fyles TW, Beriwal S, Alfieri J, Lim KS, Harkenrider MM, Small W Jr, Klopp AH, Stewart A, Yashar CM, Bosch WR, Jhingran A, Jolicoeur M, Gaffney DK. Intensity Modulated Radiation Therapy for Vulvar Carcinoma: Changes in Practice Over 5 Years. Int J Radiat Oncol Biol Phys, 96(20: E295-E296, 2016.
  49. Hamstra DA, Mariados NF, Shah DK, Kurtzman SM, Sylvester JE, Zimberg SH, Hudes RS,  Karsh L, Logsdon MD, Beyer DC, Kos M, Hsi RA, Forsythe K, Soffen EM, Francke PM, Zhang H, DeWeese TL, Ellis RJ, Mantz CA, Bosch WR, Michalski JM. Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys, 96(5):939, 2016.
  50. Caruthers D, Brame S, Palta JR, Hagan MP, Wilson E, Cowan C, Yun L, Brown S, DeBerry LM, Mutic S, Bosch WR, Robinson CG, Michalski JM, Abraham CD. Development and Implementation of Quality Measures for the Survey Based Performance Assessment of Radiation Therapy in the VA. Int J Radiat Oncol Biol Phys, 99(2): E391-2, 2017.